Literature DB >> 19665433

Protein-binding microarrays: probing disease markers at the interface of proteomics and genomics.

Jan Kerschgens1, Tanja Egener-Kuhn, Nicolas Mermod.   

Abstract

DNA-binding proteins mediate a variety of crucial molecular functions, such as transcriptional regulation and chromosome maintenance, replication and repair, which in turn control cell division and differentiation. The roles of these proteins in disease are currently being investigated using microarray-based approaches. However, these assays can be difficult to adapt to routine diagnosis of complex diseases such as cancer. Here, we review promising alternative approaches involving protein-binding microarrays (PBMs) that probe the interaction of proteins from crude cell or tissue extracts with large collections of synthetic or natural DNA sequences. Recent studies have demonstrated the use of these novel PBM approaches to provide rapid and unbiased characterization of DNA-binding proteins as molecular markers of disease, for example cancer progression or infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19665433     DOI: 10.1016/j.molmed.2009.06.004

Source DB:  PubMed          Journal:  Trends Mol Med        ISSN: 1471-4914            Impact factor:   11.951


  3 in total

1.  Elevated pressure improves the extraction and identification of proteins recovered from formalin-fixed, paraffin-embedded tissue surrogates.

Authors:  Carol B Fowler; Ingrid E Chesnick; Cedric D Moore; Timothy J O'Leary; Jeffrey T Mason
Journal:  PLoS One       Date:  2010-12-08       Impact factor: 3.240

2.  Protein-binding microarray analysis of tumor suppressor AP2α target gene specificity.

Authors:  Jan Kerschgens; Stéphanie Renaud; Frédéric Schütz; Luigino Grasso; Tanja Egener-Kuhn; Jean-François Delaloye; Hans-Anton Lehr; Horst Vogel; Nicolas Mermod
Journal:  PLoS One       Date:  2011-08-18       Impact factor: 3.240

3.  Screening for protein-DNA interactions by automatable DNA-protein interaction ELISA.

Authors:  Luise H Brand; Carsten Henneges; Axel Schüssler; H Üner Kolukisaoglu; Grit Koch; Niklas Wallmeroth; Andreas Hecker; Kerstin Thurow; Andreas Zell; Klaus Harter; Dierk Wanke
Journal:  PLoS One       Date:  2013-10-11       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.